Literature DB >> 21343484

Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization.

Ajita Deodhar1, Timm Dickfeld, Gordon W Single, William C Hamilton, Raymond H Thornton, Constantinos T Sofocleous, Majid Maybody, Mithat Gónen, Boris Rubinsky, Stephen B Solomon.   

Abstract

OBJECTIVE: Irreversible electroporation is a nonthermal ablative tool that uses direct electrical pulses to create irreversible membrane pores and cell death. The ablation zone is surrounded by a zone of reversibly increased permeability; either zone can cause cardiac arrhythmias. Our purpose was to establish a safety profile for the use of irreversible electroporation close to the heart.
MATERIALS AND METHODS: The effect of unsynchronized and synchronized (with the R wave on ECG) irreversible electroporation in swine lung and myocardium was studied in 11 pigs. Twelve lead ECG recordings were analyzed by an electrophysiologist for the presence of arrhythmia. Ventricular arrhythmias were categorized as major events. Minor events included all other dysrhythmias or ECG changes. Cardiac and lung tissue was submitted for histopathologic analysis. Electrical field modeling was performed to predict the distance from the applicators over which cells show electroporation-induced increased permeability.
RESULTS: At less than or equal to 1.7 cm from the heart, fatal (major) events occurred with all unsynchronized irreversible electroporation. No major and three minor events were seen with synchronized irreversible electroporation. At more than 1.7 cm from the heart, two minor events occurred with only unsynchronized irreversible electroporation. Electrical field modeling correlates well with the clinical results, revealing increased cell membrane permeability up to 1.7 cm away from the applicators. Complete lung ablation without intervening live cells was seen. No myocardial injury was seen.
CONCLUSION: Unsynchronized irreversible electroporation close to the heart can cause fatal ventricular arrhythmias. Synchronizing irreversible electroporation pulse delivery with absolute refractory period avoids significant cardiac arrhythmias.

Entities:  

Mesh:

Year:  2011        PMID: 21343484      PMCID: PMC4500941          DOI: 10.2214/AJR.10.4490

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  26 in total

1.  Modeling electroporation in a single cell. I. Effects Of field strength and rest potential.

Authors:  K A DeBruin; W Krassowska
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

2.  A review of parameters for the bioelectrical characterization of breast tissue.

Authors:  J Jossinet; M Schmitt
Journal:  Ann N Y Acad Sci       Date:  1999-04-20       Impact factor: 5.691

3.  Perivascular and intralesional tissue necrosis after hepatic cryoablation: results in a porcine model.

Authors:  S M Weber; F T Lee; D O Chinn; T Warner; S G Chosy; D M Mahvi
Journal:  Surgery       Date:  1997-10       Impact factor: 3.982

4.  Cancer cells ablation with irreversible electroporation.

Authors:  Liron Miller; Jonathan Leor; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2005-12

5.  Radiofrequency versus microwave ablation in a hepatic porcine model.

Authors:  Andrew S Wright; Lisa A Sampson; Thomas F Warner; David M Mahvi; Fred T Lee
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

6.  Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation.

Authors:  Edward W Lee; Christopher T Loh; Stephen T Kee
Journal:  Technol Cancer Res Treat       Date:  2007-08

7.  Irreversible electroporation in medicine.

Authors:  Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

Review 8.  Technical aspects of needle aspiration lung biopsy: a personal perspective.

Authors:  E H Moore
Journal:  Radiology       Date:  1998-08       Impact factor: 11.105

9.  Dielectric properties of VX-2 carcinoma versus normal liver tissue.

Authors:  S R Smith; K R Foster; G L Wolf
Journal:  IEEE Trans Biomed Eng       Date:  1986-05       Impact factor: 4.538

10.  Significance of total vascular exclusion for hepatic cryotherapy: an experimental study.

Authors:  W Jungraithmayr; M Szarzynski; H Neeff; J Haberstroh; G Kirste; A Schmitt-Graeff; E H Farthmann; S Eggstein
Journal:  J Surg Res       Date:  2004-01       Impact factor: 2.192

View more
  47 in total

1.  Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model.

Authors:  Stefan Fritz; Christof M Sommer; Thomas Longerich; Clemens Kuhn-Neureuther; Boris Radeleff; Jens Werner; Thilo Hackert
Journal:  Langenbecks Arch Surg       Date:  2017-04-04       Impact factor: 3.445

Review 2.  Decision Making: Thermal Ablation Options for Small Renal Masses.

Authors:  Colin J McCarthy; Debra A Gervais
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

3.  Pulmonary Microwave Ablation Near the Heart: Antenna Positioning Can Mitigate Cardiac Complications in a Porcine Model.

Authors:  George A Carberry; Elisabetta Nocerino; Peter J Mason; Denise J Schwahn; Scott Hetzel; Alyssa M Turnquist; Fred T Lee; Christopher L Brace
Journal:  Radiology       Date:  2016-10-12       Impact factor: 11.105

4.  Irreversible electroporation: Proceed with caution.

Authors:  Kedar K Aras; Igor R Efimov
Journal:  Heart Rhythm       Date:  2018-07-29       Impact factor: 6.343

5.  Skin regeneration with all accessory organs following ablation with irreversible electroporation.

Authors:  Alexander Golberg; Martin Villiger; G Felix Broelsch; Kyle P Quinn; Hassan Albadawi; Saiqa Khan; Michael T Watkins; Irene Georgakoudi; William G Austen; Marianna Bei; Brett E Bouma; Martin C Mihm; Martin L Yarmush
Journal:  J Tissue Eng Regen Med       Date:  2017-05-23       Impact factor: 3.963

6.  [Irreversible electroporation - a new kid on the block?].

Authors:  O Kosiek; K Strach; J Ricke; M Pech
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

Review 7.  Lung cancer ablation: what is the evidence?

Authors:  Thierry de Baere; Geoffroy Farouil; Frederic Deschamps
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

8.  Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft.

Authors:  Christoph Niessen; Ernst Michael Jung; Walter A Wohlgemuth; Benedikt Trabold; Michael Haimerl; Andreas Schreyer; Christian Stroszczynski; Philipp Wiggermann
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

Review 9.  Diagnostic and therapeutic management of hepatocellular carcinoma.

Authors:  Francesco Bellissimo; Marilia Rita Pinzone; Bruno Cacopardo; Giuseppe Nunnari
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 10.  Tumor ablation: common modalities and general practices.

Authors:  Erica M Knavel; Christopher L Brace
Journal:  Tech Vasc Interv Radiol       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.